The increase in Ang2 protein concentration seen within mdx/utrn+/− mice is consistent with a proteome profiling analysis conducted on young 4–10-year-old human patients with DMD, which also reported elevated Ang2 protein levels in patient serums [26]. This evidence concerns the gene ANGPT2 and Duchenne muscular dystrophy.